Patents by Inventor Viswanath Devanarayan

Viswanath Devanarayan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COPD Biomarker Signatures
    Publication number: 20180004895
    Abstract: The present invention relates to methods of detecting differentially expressed protein expression indicative of COPD in a test sample. The detection of circulating levels of proteins within an identified COPD biomarker signature can aid in COPD diagnosis and disease monitoring, as well as in the prediction of responses to therapeutics. Evaluation of the biomarker signatures disclosed, or a subset of biomarkers thereof, provides a level of discrimination not found with individual markers.
    Type: Application
    Filed: July 14, 2017
    Publication date: January 4, 2018
    Applicant: Lineagen, Inc.
    Inventors: Francois Gervais, Viswanath Devanarayan
  • Method for Detection of Ischemic Strokes
    Publication number: 20170242039
    Abstract: The present invention relates to the identification and use of diagnostic markers for ischemic stroke of the lacunar subtype. The invention relates to devices and kits for performing these methods.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 24, 2017
    Applicants: Abbott GmbH & Co. KG, Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca (HUVH IR)
    Inventors: Ingo Curdt, Stuart Blincko, Jens Dhein, Viswanath Devanarayan, Joan Montaner Villalonga
  • Method for Detection of Ischemic Strokes
    Publication number: 20130122519
    Abstract: The present invention relates to the identification and use of diagnostic markers for ischemic stroke of the lacunar subtype. The invention relates to devices and kits for performing these methods.
    Type: Application
    Filed: July 28, 2011
    Publication date: May 16, 2013
    Applicants: Institut de recerca Hoepital Universitari Vall D'Heerbron, Fundacio Privada, ABBOTT GMBH & CO. KG
    Inventors: Ingo Curdt, Stuart Blincko, Jens Dhein, Viswanath Devanarayan, Joan Montaner Villalonga
  • METHODS FOR PREDICTING SENSITIVITY TO TREATMENT WITH A TARGETED TYROSINE KINASE INHIBITOR
    Publication number: 20120190563
    Abstract: Methods and kits for predicting the sensitivity of a cancer to treatment with a targeted tyrosine kinase inhibitor are disclosed.
    Type: Application
    Filed: May 4, 2011
    Publication date: July 26, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Evelyn M. McKeegan, Peter Ansell, Barry L. Dowell, Ke Zhang, Viswanath Devanarayan
  • BIOMARKERS AND METHODS FOR DETECTING ALZHEIMER'S DISEASE
    Publication number: 20120178637
    Abstract: Methods for classifying a test sample as indicative of Alzheimer's disease use protein and peptide biomarkers that are differentially expressed in the cerebral spinal fluid (CSF) of subjects with Alzheimer's disease relative to age-matched controls. The methods also use protein and peptide signatures indicative of Alzheimer's disease. Microarrays and kits for detecting the protein and peptide biomarkers in CSF samples can be used to classify Alzheimer's disease state from test samples.
    Type: Application
    Filed: July 7, 2010
    Publication date: July 12, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Viswanath Devanarayan, Melanie Joy Patterson, Jeffrey F. Waring, David Witte
  • METHODS FOR PREDICTING SENSITIVITY TO TREATMENT WITH A TARGETED TYROSINE KINASE INHIBITOR
    Publication number: 20120115745
    Abstract: The present disclosure relates generally to the evaluation and/or treatment of a subject having or suspected of having a neoplastic condition, and in particular to the use of biomarkers for identifying patients receptive to a certain drug therapy, and which permit monitoring of patient response to such therapy.
    Type: Application
    Filed: November 9, 2011
    Publication date: May 10, 2012
    Inventors: Evelyn M. McKeegan, Peter Ansell, Barry L. Dowell, Ke Zhang, Viswanath Devanarayan, Arunava Charkravartty
  • COPD BIOMARKER SIGNATURES
    Publication number: 20110160070
    Abstract: The present invention relates to methods of detecting differentially expressed protein expression indicative of COPD in a test sample. The detection of circulating levels of proteins within an identified COPD biomarker signature can aid in COPD diagnosis and disease monitoring, as well as in the prediction of responses to therapeutics. Evaluation of the biomarker signatures disclosed, or a subset of biomarkers thereof, provides a level of discrimination not found with individual markers.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 30, 2011
    Applicant: Lineagen, Inc.
    Inventors: Francois Gervais, Viswanath Devanarayan
  • COMPANION DIAGNOSTIC ASSAYS FOR CANCER THERAPY
    Publication number: 20100028889
    Abstract: Methods for identifying cancer patients eligible to receive Bcl-2 family inhibitor therapy and for monitoring patient response to Bcl-2 family inhibitor therapy comprise assessment of the expression levels of the biomarker combinations set out in TABLES 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 in a patient tissue sample. The methods of the invention allow more effective identification of patients to receive Bcl-2 family inhibitor therapy and of determination of patient response to the therapy.
    Type: Application
    Filed: June 24, 2009
    Publication date: February 4, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Mark G. Anderson, Paul E. Kroeger, Saul H. Rosenberg, Stephen K. Tahir, John A. Wass, Christin Tse, Viswanath Devanarayan